Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
8,627,972
-
Share change
-
+4,388,702
-
Total reported value
-
$18,126,000
-
Put/Call ratio
-
57%
-
Price per share
-
$2.10
-
Number of holders
-
22
-
Value change
-
+$8,662,521
-
Number of buys
-
16
-
Number of sells
-
7
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2016
As of 31 Dec 2016,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,627,972 shares.
The largest 10 holders included
NEA Management Company, LLC, GOLDMAN SACHS GROUP INC, ACUTA CAPITAL PARTNERS, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Anson Funds Management LP, SG Americas Securities, LLC, K2 PRINCIPAL FUND, L.P., OXFORD ASSET MANAGEMENT, UBS Group AG, and MILLENNIUM MANAGEMENT LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.